跳至主要内容
临床试验/NCT02097485
NCT02097485已完成2 期

A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation

Dr. Reddy's Laboratories Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment

研究概览

简要总结

The purpose of the study was to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.

详细描述

This was a double-blind, randomised, vehicle-controlled, parallel group study in males and females, aged three years and older with active head lice infestation. The study was designed to assess the ovicidal efficacy of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at the study site. This study used an ex vivo method of assessment for ovicidal efficacy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male or female based on medical history
  • Six months of age or older.
  • Has an active head lice infestation with a minimum of 3 live head lice and at least 10 undamaged and unhatched head lice eggs in their hair.
  • Agrees to an examination for head lice and compliance with the study procedures.
  • All adult subjects must sign a written voluntary informed consent. For minors, the parent/ legal guardian agrees to the subject participating in the study as determined by the signing of an assent of informed consent.

排除标准

  • Has scalp disease or a history of allergies or prior reactions to any head lice products.
  • Has a condition that, in the opinion of the Investigator, may interfere with the study.
  • Is receiving systemic or topical medication, which in the opinion of the Investigator, may compromise the integrity of the safety and/or efficacy assessments.
  • Had treatment (over-the-counter (OTC) or home remedy medication) for head lice within 14 days prior to Day
  • Has received an investigational agent within 30 days prior to Day 0.

研究组 & 干预措施

Abametapir Lotion 0.74% w/w

Active Comparator

Topically administered to hair and scalp for 10 minutes application.

干预措施: Abametapir Lotion 0.74% w/w (Drug)

Vehicle Lotion

Placebo Comparator

Administered to scalp and hair for 10 minutes application.

干预措施: Vehicle Lotion (Drug)

结局指标

主要结局

Percentage of Hatched Eggs Pre Treatment Relative to Post Treatment

时间窗: 14 days

Percentage of hatched eggs pre treatment relative to percentage of hatched eggs post treatment for the abametapir and vehicle treated eggs following 14 day incubation. The difference between post treatment percent hatching and pre-treatment percent hatching was calculated i.e. post-treatment minus pre-treatment hatching percent.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ovicidal Efficacy and Safety of Abametapir Lotion... | 临床试验